Annals of Oncology

In this issue:

In this issue
Ann Oncol 5: 191.
[PDF] [Request Permissions]

Contents of the next issue:

Contents of the next issue
Ann Oncol 5: 191.
[PDF] [Request Permissions]

News:

FDA remains liberal
Ann Oncol 5: 192.
[PDF] [Request Permissions]

Turmoil over drugs in Italy
Ann Oncol 5: 192.
[PDF] [Request Permissions]

Surgeon General Elders for a more liberal drug policy
Ann Oncol 5: 193.
[PDF] [Request Permissions]

More AIDS debate
Ann Oncol 5: 193-194.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 5: 194-195.
[PDF] [Request Permissions]

Book reviews:

G. Domenighetti

Book review
Ann Oncol 5: 195.
[PDF] [Request Permissions]

F. Cavalli

Book review
Ann Oncol 5: 231.
[PDF] [Request Permissions]

Ch. Rochlitz

Book review
Ann Oncol 5: 285.
[PDF] [Request Permissions]

Editorial:

Late cardiac effects of adjuvant therapy: Too soon to tell?
Ann Oncol 5: 196-198.
[PDF] [Request Permissions]

Special articles:

P. N. Butow, S. M. Dunn, M. H. N. Tattersall, and Q. J. Jones

Patient participation in the cancer consultation: Evaluation of a question prompt sheet
Ann Oncol 5: 199-204.
[Abstract] [PDF] [Request Permissions]

Commentary:

A. Gescher and A. Mantovani

Exploiting tumour biology: Novel approaches in cancer therapy: ESBP Otzenhausen Conference, 6-8th September 1993
Ann Oncol 5: 205-207.
[PDF] [Request Permissions]

Original articles:

P. Valagussa, M. Zambetti, S. Biasi, A. Moliterni, R. Zucali, and G. Bonadonna

Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancer
Ann Oncol 5: 209-216.
[Abstract] [PDF] [Request Permissions]

M. E. H. M. Van Hoef, I. Baumann, C. Lange, T. Luft, E. A. de Wynter, M. Ranson, G. R. Morgenstern, A. Yvers, T. M. Dexter, N. G. Testa, and A. Howell

Dose-escalating induction chemotherapy supported by lenograstim preceding high-dose consolidation chemotherapy for advanced breast cancer: Selection of the most acceptable regimen to induce maximal tumor response and investigation of the optimal time to collect peripheral blood progenitor cells for haematological rescue after high-dose consolidation chemotherapy
Ann Oncol 5: 217-224.
[Abstract] [PDF] [Request Permissions]

J. I. Mayordomo, L. Paz-Ares, F. Rivera, M. López-Brea, E. López Martín, C. Mendiola, M. T. Díaz-Puente, P. Lianes, M. D. García-Prats, and H. Cortés-Funes

Ovarian and extragonadal malignant germ-cell tumors in females: A single-institution experience with 43 patients
Ann Oncol 5: 225-231.
[Abstract] [PDF] [Request Permissions]

H. J. Weh, H. J. Wilke, J. Dierlamm, U. Klaassen, R. Siegmund, H. J. Illiger, A. Schalhorn, E. D. Kreuser, U. Hilgenfeld, B. Steinke, W. Weber, O. Burkhard, A. Zoller, J. Pfitzner, R. Subert, R. Kriebel, and D. K. Hossfeld

Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma: A multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO)
Ann Oncol 5: 233-237.
[Abstract] [PDF] [Request Permissions]

M. Findlay, A. Hill, D. Cunningham, A. Norman, M. Nicolson, H. Ford, J. Husband, C. Evans, and R. Carter

Protracted venous infusion 5-fluorouracil and interferon- in advanced and refractory colorectal cancer
Ann Oncol 5: 239-243.
[Abstract] [PDF] [Request Permissions]

H. Haarstad, A.-B. Jacobsen, S. A. Schjølseth, T. Risberg, and S. D. Fosså

Interferon-, 5-FU and prednisone in metastatic renal cell carcinoma: A phase II study
Ann Oncol 5: 245-248.
[Abstract] [PDF] [Request Permissions]

A. S. Coates and E. Segelov

Long term response to chemotherapy in patients with visceral metastatic melanoma
Ann Oncol 5: 249-251.
[Abstract] [PDF] [Request Permissions]

R. A. Joss, M. Bacchi, K. Buser, V. Kirchner, H. Neuenschwander, B. Orth, M. S. Aapro, and B. Thürlimann

Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients
Ann Oncol 5: 253-258.
[Abstract] [PDF] [Request Permissions]

L. J. C. van Warmerdam, J. Verweij, H. Rosing, J. H. M. Schellens, R. A. A. Maes, and J. H. Beijnen

Limited sampling models for topotecan pharmacokinetics
Ann Oncol 5: 259-264.
[Abstract] [PDF] [Request Permissions]

A. Younes, J. Drach, R. Katz, D. Jendiroba, M. H. Sabourian, A. H. Sarris, F. Swan, Jr, D. Hill, F. Cabanillas, R. Ford, and M. Andreeff

Growth inhibition of follicular small-cleaved-cell lymphoma cells in short-term culture by interleukin-3
Ann Oncol 5: 265-268.
[Abstract] [PDF] [Request Permissions]

M. Caraglia, A. Pinto, P. Correale, V. Zagonel, G. Genua, A. Leardi, S. Pepe, A. R. Bianco, and P. Tagliaferri

5-Aza-2'-deoxycytidine induces growth inhibition and upregulation of epidermal growth factor receptor on human epithelial cancer cells
Ann Oncol 5: 269-276.
[Abstract] [PDF] [Request Permissions]

Clinical case:

K. Hoekman, J. van Doom, T. Gloudemans, O. S. Hoekstra, J. A. Maassen, J. B. Vermorken, J. Wagstaff, and H. M. Pinedo

Tumour-induced hypoglycaemia: A case report
Ann Oncol 5: 277-281.
[PDF] [Request Permissions]

Short reports:

Y. Cormier, E. Eisenhauer, A. Muldal, R. Gregg, J. Ayoub, G. Goss, D. Stewart, P. Tarasoff, and D. Wong

Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC): A study of the National Cancer Institute of Canada Clinical Trials Group
Ann Oncol 5: 283-285.
[Abstract] [PDF] [Request Permissions]

D. F. Moore, Jr, R. Pazdur, J. L. Abbruzzese, J. A. Ajani, D. W. Dubovsky, J. L. Wade, III, R. J. Belt, C. Mangold, B. Bready, and R. J. Winn

Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma
Ann Oncol 5: 286-287.
[Abstract] [PDF] [Request Permissions]

M. A. Dimopoulos, D. M. Weber, H. Kantarjian, M. Keating, and R. Alexanian

2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine
Ann Oncol 5: 288-289.
[Abstract] [PDF] [Request Permissions]

Letters:

C. Cotto, E. Quoix, F. Thomas, S. Henane, and V. Trillet-Lenoir

Phase I study of the somatostatin analogue somatuline in refractory small-cell lung carcinoma
Ann Oncol 5: 290.
[PDF] [Request Permissions]

A. Falcone, C. Cianci, E. Pfanner, M. Bertuccelli, I. Brunetti, M. P. Muttini, F. Dargenio, S. Ricci, and P. F. Conte

Continuous-infusion 5-fluorouracil in metastatic colorectal cancer patients pretreated with bolus 5-fluorouracil: Clinical evidence of incomplete cross-resistance
Ann Oncol 5: 291.
[PDF] [Request Permissions]

Advertisements in this issue:

ESMO & ESO Postgraduate course
Ann Oncol 5: 292-294.
[PDF] [Request Permissions]

Classified advertisements from ESMO members and meeting announcements
Ann Oncol 5: 295.
[PDF] [Request Permissions]

SmithKline Beecham Pharmaceuticals
Ann Oncol 5: 296.
[PDF] [Request Permissions]

Bristol-Myers Squibb
Ann Oncol 5: 296.
[PDF] [Request Permissions]

ESMO membership applications forms
Ann Oncol 5: 296.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.